Multiple Myeloma

ELDA qASO-PCR for High Sensitivity Detection of Tumor Cells in Bone Marrow and Peripheral Blood.- EuroFlow-Based Next-Generation Flow Cytometry for Detection of Circulating Tumor Cells and Minimal Residual Disease in Multiple Myeloma.- Cytoplasmic Immunoglobulin vs DNA Analysis by Flow Cytometry.- Deep Profiling of the Immune System of Multiple Myeloma Patients by Cytometry by Time of Flight (CyTOF).- Fluorescence In Situ Hybridization (FISH) in Multiple Myeloma.- Whole Exome Sequencing in Multiple Myeloma to Identify Somatic Single Nucleotide Variants and Key Translocations Involving Immunoglobulin Loci and MYC.- RNA-Sequencing from Low-Input Material in Multiple Myeloma for Application in Clinical Routine.- Protocol for M3P: A Comprehensive and Clinical Oriented Targeted Sequencing Panel for Routine Molecular Analysis in Multiple Myeloma.- Analysis of Circulating Tumor DNA.- Detection of Cross-Sample Contamination in Multiple MyelomaSamples and Sequencing Data.- Analysis of Global Gene Expression Profiles.- Genome Wide Mapping of Methylated and Hydroxyl-Methylated Cytosines using a Modified HpaII Tiny Fragment Enrichment by Ligation Mediated PCR Tagged Sequencing Protocol.- A Rapid and Robust Protocol for Reduced Representation Bisulfite Sequencing in Multiple Myeloma.- Microfluidic Production and Application of Lipid Nanoparticles for Nucleic Acid Transfection.- Microfluidic Assembly of Liposomes with Tunable Size and Co-Loading Capabilities.